Search Results - "Fan, Zongyu"

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China by Fan, Zongyu, Hui, Rongrong, Ju, Houyu, Wu, Yunteng, Ma, Xuhui, Song, Hao, Liu, Yang, Rui, Mengyu, Geng, Xinrong, Zhao, Minqi, Xin, Yingye, Wei, Dongliang, Ren, Guoxin

“…The KEYNOTE-048 and KEYNOTE-040 study have demonstrated the efficacy of pembrolizumab in recurrent or metastatic squamous cell carcinoma of the head and neck…”
Get full text

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma by Ju, Houyu, Wei, Dongliang, Wu, Yunteng, Liu, Yang, Ding, Qi, Rui, Mengyu, Fan, Zongyu, Yao, Yanli, Hu, Jingzhou, Ren, Guoxin

“…Pembrolizumab with cisplatin and 5‐fluorouracil showed survival benefit but relatively high occurrence of treatment‐related adverse events (TRAEs) for…”
Get full text

Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission by Yan, Jiuliang, Wang, Xiaofeng, Fan, Zongyu, Xu, Yiqing, Zhang, Yingzi, Liu, Yi, Guo, Lei, Liu, Dongli

“…Hepatocellular carcinoma (HCC) is highly metastatic and invasive. CircRNA participates in gene regulation of multiple tumor metastases, but little is known…”
Get full text

The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma by Hui, Rongrong, Liu, Xiulan, Fan, Zongyu, Ji, Honghai, Wei, Dongliang, Ren, Guoxin

“…The prognosis of patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) that are refractory to programmed cell death protein 1…”
Get full text